We are live on
!
Find out more
BA
Bristlecone Advisors Portfolio holdings
AUM
$1.2B
1-Year Est. Return
19.79%
This Fund
S&P 500
This Quarter
Est. Return
+8%
1 Year Est. Return
+19.79%
3 Year Est. Return
+102.73%
5 Year Est. Return
+112.96%
10 Year Est. Return
+315.34%
AUM
$739M
AUM Growth
+$77.1M
(+12%)
Cap. Flow
+$29M
Cap. Flow
% of AUM
3.92%
Top 10 Holdings %
Top 10 Hldgs %
40.19%
Holding
218
New
12
Increased
130
Reduced
40
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LONA
LeonaBio Inc
LONA
|
+$13.3M |
| 2 |
Goldman Sachs Access Ultra Short Bond ETF
GSST
|
+$2.32M |
| 3 |
Palantir
PLTR
|
+$1.94M |
| 4 |
Microsoft
MSFT
|
+$1.69M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$1.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Travelers Companies
TRV
|
+$3.57M |
| 2 |
Fortinet
FTNT
|
+$3.46M |
| 3 |
RTX Corp
RTX
|
+$2.14M |
| 4 |
Colgate-Palmolive
CL
|
+$1.8M |
| 5 |
Novartis
NVS
|
+$1.66M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.99% |
| 2 | Consumer Discretionary | 6.35% |
| 3 | Healthcare | 6% |
| 4 | Financials | 5.72% |
| 5 | Communication Services | 5.03% |
Similar funds
WCWM
P
SFI
BCM
SAM
4CM
SAM
SIMG
Bristlecone Advisors's Q2 2021 Portfolio in Review
As of Q2 2021, Bristlecone Advisors held 218 positions worth $739M, up 12% from $662M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Bristlecone Advisors deployed $29M of net new capital in Q2 2021, opening 12 new positions and adding to 130 existing holdings. Its largest new stake was LeonaBio Inc: 76,156 shares worth $7.8M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Colgate-Palmolive, an estimated $1.8M trimmed.
- Bristlecone Advisors's largest Q2 2021 buy was LeonaBio Inc: 76,156 shares worth $7.8M.
- Bristlecone Advisors added most to Goldman Sachs Access Ultra Short Bond ETF in Q2 2021, an estimated $2.32M increase.
- Bristlecone Advisors's biggest Q2 2021 reduction was Colgate-Palmolive, cutting an estimated $1.8M.
- Bristlecone Advisors fully exited Travelers Companies in Q2 2021, selling an estimated $3.57M.
- Bristlecone Advisors's ten largest holdings make up 40% of its $739M portfolio in Q2 2021.
- Bristlecone Advisors opened 12 new positions and closed 5 in Q2 2021.
- Bristlecone Advisors's portfolio value rose 12% quarter-over-quarter to $739M.
Based on Bristlecone Advisors's 13F filing for Q2 2021, filed 21 Jul 2021.